February 2021 Metabolic Disease Related News from our Partners at Consultant 360

What Do You Need to Know About Continuous Glucose Monitoring?

In this month's column, Andrea Cedeno, MD, and Kim A. Carmichael, MD, answer questions about continuous glucose monitors, the appropriate patient populations, potential adverse reactions, and more.

Does SSRI Use Increase the Risk of Type 2 Diabetes in Children?

While the relationship between selective serotonin reuptake inhibitors use and the risk of type 2 diabetes in adults has been a matter of concern for health care providers, little is known about this association in children and adolescents. In a recent study, researchers examined the safety of SSRI use in this patient population, and how the use of SSRIs impacted their risk for developing type 2 diabetes. 

Aldosteronism Testing Is Rare, Despite Guidelines

Despite guideline recommendations, evidence suggests there is inadequate testing for primary aldosteronism among patients with treatment-resistant hypertension. In a recent study, researchers examined the rates of this testing in US veterans with treatment-resistant hypertension, and the associations of hypertension management.

Paul Jellinger, MD, MACE, on Managing Lipids in a Challenging Patient

In part 2 of our series on lipid management, Dr Paul Jellinger explains the answer to the quiz question from part 1, the AACE lipid guidelines, and the role of renal disease in managing this patient.

USPSTF Updates Asymptomatic Carotid Artery Stenosis Screening Recommendations

The US Preventive Services Task Force has released new recommendations on screening for asymptomatic carotid artery stenosis in adults.